11 Haroche Haroche J J Cohen-Aubart Cohen-Aubart F F Emile Emile JF JF Donadieu Donadieu J J Amoura Amoura Z Z Vemurafenib as first line therapy in BRAF-mutated Langerhans cell histiocytosis Vemurafenib as first line therapy in BRAF-mutated Langerhans cell histiocytosis J Am Acad Dermatol J Am Acad Dermatol 2015 2015 Jul Jul 73 73 1 1 e29 e29 30 30 26089069 26089069. Here, BRAF is linked to Langerhans cell histiocytosis.